Search Results - "Pylypenko, Halyna"

Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.

Authors: Mateos, Maria V. Gavriatopoulou, Maria Facon, Thierry et al.

Source: Journal of Hematology & Oncology. 4/13/2021, Vol. 14 Issue 1, p1-5. 5p.

A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia.

Authors: Kipps, Thomas J. Eradat, Herbert Grosicki, Sebastian et al.

Source: Leukemia & Lymphoma. Oct2015, Vol. 56 Issue 10, p2826-2833. 8p.

Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study^*.

Authors: Robak, Tadeusz Huang, Huiqiang Jin, Jie et al.

Source: Leukemia & Lymphoma. Jan2019, Vol. 60 Issue 1, p172-179. 8p.